Companies in #Seasonal influenza (mRNA-1010)
Found 1 company operating in this sector.
Moderna is a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The company develops mRNA medicines for infectious diseases, cancer, rare diseases, and autoimmune conditions, with the first commercial product (Spikevax COVID-19 vaccine) approved in 2020 and ongoing development of seasonal flu, RSV, and oncology programs.